Related references
Note: Only part of the references are listed.Simultaneous Target-Mediated Drug Disposition Model for Two Small-Molecule Compounds Competing for Their Pharmacological Target: Soluble Epoxide Hydrolase
Nan Wu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)?
Bruce D. Hammock et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Perioperative Gabapentinoids Deflating the Bubble
Evan D. Kharasch et al.
ANESTHESIOLOGY (2020)
Increased expression of soluble epoxide hydrolase in the brain and liver from patients with major psychiatric disorders: A role of brain - liver axis
Jiancheng Zhang et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Bioisosteric substitution of adamantane with bicyclic lipophilic groups improves water solubility of human soluble epoxide hydrolase inhibitors
Vladimir Burmistrov et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Soluble Epoxide Hydrolase Regulation of Lipid Mediators Limits Pain
Karen M. Wagner et al.
NEUROTHERAPEUTICS (2020)
An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease
Anamitra Ghosh et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain
Kin Sing Stephen Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea
Debin Wan et al.
FRONTIERS IN PHARMACOLOGY (2019)
Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases
Dipak Panigrahy et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
Cindy B. McReynolds et al.
FRONTIERS IN PHARMACOLOGY (2019)
Drug-Target Residence Time Affects in Vivo Target Occupancy through Multiple Pathways
Kin Sing Stephen Lee et al.
ACS CENTRAL SCIENCE (2019)
Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis
A. Guedes et al.
EQUINE VETERINARY JOURNAL (2017)
Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers
Sumanta Kumar Goswami et al.
LIFE SCIENCES (2017)
Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases
Karen M. Wagner et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Probing the orientation of inhibitor and epoxy-eicosatrienoic acid binding in the active site of soluble epoxide hydrolase
Kin Sing Stephen Lee et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor
Aili L. Lazaar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors
Jun-Yan Liu et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Opioid Use in the Management of Diabetic Peripheral Neuropathy (DPN) in a Large Commercially Insured Population
Pravinkumar R. Patil et al.
CLINICAL JOURNAL OF PAIN (2015)
The 2014 Bernard B. Brodie Award Lecture-Epoxide Hydrolases: Drug Metabolism to Therapeutics for Chronic Pain
Sean D. Kodani et al.
DRUG METABOLISM AND DISPOSITION (2015)
The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC
Yasuhiro Tsume et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo Efficacy
Kin Sing Stephen Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Investigating the role of neuropathic pain relief in decreasing gait variability in diabetes mellitus patients with neuropathic pain: a randomized, double-blind crossover trial
Surshen Karmakar et al.
JOURNAL OF NEUROENGINEERING AND REHABILITATION (2014)
Soluble Epoxide Hydrolase Inhibition Is Antinociceptive in a Mouse Model of Diabetic Neuropathy
Karen Wagner et al.
JOURNAL OF PAIN (2014)
Forster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase
Kin Sing Stephen Lee et al.
ANALYTICAL BIOCHEMISTRY (2013)
Rationally Designed Multitarget Agents Against Inflammation and Pain
S. H. Hwang et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates Diet-induced Endoplasmic Reticulum Stress in Liver and Adipose Tissue
Ahmed Bettaieb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor
Patricia L. Podolin et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
Use of a soluble epoxide hydrolase inhibitor as an adjunctive analgesic in a horse with laminitis
Alonso G. P. Guedes et al.
VETERINARY ANAESTHESIA AND ANALGESIA (2013)
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice
Dipak Panigrahy et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Discovery of Inhibitors of Soluble Epoxide Hydrolase: A Target with Multiple Potential Therapeutic Indications
Hong C. Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia
Sampath-Kumar Anandan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Investigation of Human Exposure to Triclocarban after Showering and Preliminary Evaluation of Its Biological Effects
Nils Helge Schebb et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2011)
Combination Drug Therapy for Chronic Pain: A Call for More Clinical Studies
Jianren Mao et al.
JOURNAL OF PAIN (2011)
1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure-Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain
Tristan E. Rose et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Arachidonic acid cytochrome P450 epoxygenase pathway
Arthur A. Spector
JOURNAL OF LIPID RESEARCH (2009)
Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways
Bora Inceoglu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Orally bioavailable potent soluble epoxide hydrolase inhibitors
Sung Hee Hwang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The soluble epoxide hydrolase as a pharmaceutical target for hypertension
Nipavan Chiamvimonvat et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
Danyan Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase
Paul D. Jones et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels
Jeffrey J. Olearczyk et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
High-throughput pharmacokinetic method: Cassette dosing in mice associated with minuscule serial bleedings and LC/MS/MS analysis
T Watanabe et al.
ANALYTICA CHIMICA ACTA (2006)
Human soluble epoxide hydrolase: Structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids
GA Gomez et al.
PROTEIN SCIENCE (2006)
Soluble epoxide hydrolase is a therapeutic target for acute inflammation
KR Schmelzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis
GA Gomez et al.
BIOCHEMISTRY (2004)
Design, synthesis, and biological activity of 1,3-Disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility
IH Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension
JD Imig et al.
HYPERTENSION (2002)
Share Paper
